| 000 | 02568 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250516121725.0 | ||
| 264 | 0 | _c20130910 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.4161/hv.22129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRichie, Thomas L | |
| 245 | 0 | 0 |
_aClinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _cNov 2012 |
||
| 300 |
_a1564-84 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, Protozoan _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 |
_aPlasmodium falciparum _ximmunology |
| 650 | 0 | 4 |
_aSporozoites _ximmunology |
| 650 | 0 | 4 |
_aVaccines, DNA _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCharoenvit, Yupin | |
| 700 | 1 | _aWang, Ruobing | |
| 700 | 1 | _aEpstein, Judith E | |
| 700 | 1 | _aHedstrom, Richard C | |
| 700 | 1 | _aKumar, Sanjai | |
| 700 | 1 | _aLuke, Thomas C | |
| 700 | 1 | _aFreilich, Daniel A | |
| 700 | 1 | _aAguiar, Joao C | |
| 700 | 1 | _aSacci, John B | |
| 700 | 1 | _aSedegah, Martha | |
| 700 | 1 | _aNosek, Ronald A | |
| 700 | 1 | _aDe La Vega, Patricia | |
| 700 | 1 | _aBerzins, Mara P | |
| 700 | 1 | _aMajam, Victoria F | |
| 700 | 1 | _aAbot, Esteban N | |
| 700 | 1 | _aGaneshan, Harini | |
| 700 | 1 | _aRichie, Nancy O | |
| 700 | 1 | _aBanania, Jo Glenna | |
| 700 | 1 | _aBaraceros, Maria Fe B | |
| 700 | 1 | _aGeter, Tanya G | |
| 700 | 1 | _aMere, Robin | |
| 700 | 1 | _aBebris, Lolita | |
| 700 | 1 | _aLimbach, Keith | |
| 700 | 1 | _aHickey, Bradley W | |
| 700 | 1 | _aLanar, David E | |
| 700 | 1 | _aNg, Jennifer | |
| 700 | 1 | _aShi, Meng | |
| 700 | 1 | _aHobart, Peter M | |
| 700 | 1 | _aNorman, Jon A | |
| 700 | 1 | _aSoisson, Lorraine A | |
| 700 | 1 | _aHollingdale, Michael R | |
| 700 | 1 | _aRogers, William O | |
| 700 | 1 | _aDoolan, Denise L | |
| 700 | 1 | _aHoffman, Stephen L | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 8 _gno. 11 _gp. 1564-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.22129 _zAvailable from publisher's website |
| 999 |
_c22263513 _d22263513 |
||